Loading…
DIA Europe 2019 has ended
View analytic
Wednesday, February 6 • 11:15 - 11:45
#CH402: Policy 0070 Submissions – Comparison of Anonymisation Methodologies – Advantages and Disadvantages

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Session
Level: Intermediate



Learning Objectives

Comparison of anonymisation techniques and assessments; advantages and disadvantages; EMA Policy 0070 Phase I.

Chair

Ingeborg Cil, MSc


Speakers
avatar for Ingeborg Cil

Ingeborg Cil

Lead, Clinical Trial Data Anonymization, Shire Now Part of Takeda
Ingeborg Cil is Associate Director, Clinical Trial Transparency, at Shire Now Part of Takeda. She received her Master of Science in Computer Science from the Technical University Vienna. After working several years as software developer, project manager, supervisor, Ingeborg moved... Read More →


Wednesday February 6, 2019 11:15 - 11:45
Content Hub 4 Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria